Market Cap: $63.25B
Market Cap: $63.25B

Boston Scientific Corporation ( BSX ) is navigating a multifaceted landscape of operational challenges, competitive pressures, and strategic investments aimed at fortifying its position in the medical…

Boston Scientific Corporation ( BSX ) is currently navigating a complex landscape characterized by a mixture of operational challenges, strategic investments, and the pressing need for innovation with…

Boston Scientific (Ticker: BSX) is navigating a challenging environment in the medical device market, particularly highlighted by recent challenges with its Watchman device product line. The company h…

Boston Scientific Corporation (Ticker: BSX) announces significant findings from its pivotal SEISMIQ 4CE trial, marking a noteworthy advancement in the treatment of severely calcified coronary artery d…

Boston Scientific Corporation has made a significant strategic investment of $1.5 billion in MiRus LLC, aimed at expanding its footprint in the transcatheter aortic valve replacement (TAVR) market. Th…
Boston Scientific Corporation (Ticker: BSX) is taking strategic steps to enhance its capital allocation strategy through a recent filing of a shelf registration for offering 10,000,000 shares of commo…

Boston Scientific Corporation achieves a significant milestone with the FDA's 510(k) clearance of the Asurys Fluid Management System, marking an important advancement in its urology technology portfol…
Transformative Stroke Prevention in Atrial Fibrillation: Boston Scientific's WATCHMAN FLX Revolutionizes Treatment Options Boston Scientific is making headlines with its innovative WATCHMAN FLX device…
Boston Scientific Faces Class Action Lawsuit Over Alleged Securities Fraud In recent developments, Boston Scientific Corporation finds itself in the midst of a class action lawsuit related to allegati…
Boston Scientific Faces Legal Challenges Over Electrophysiology Growth Claims Boston Scientific Corporation is currently embroiled in a class action lawsuit over allegations of securities fraud relate…
Boston Scientific Under Legal Scrutiny Over Allegations of Misleading Investors Boston Scientific Corporation faces significant legal challenges as recent reports reveal ongoing class action lawsuits…
Class Action Lawsuits Spotlight Boston Scientific’s Electrophysiology Segment Concerns Recent developments regarding Boston Scientific Corporation have emerged, raising significant concerns for shareh…
Boston Scientific Faces Securities Class Action Over Alleged Misleading Statements In a significant legal development, Rosen Law Firm reminds investors who purchased common stock in Boston Scientific…
Boston Scientific Faces Legal Challenge Over Misleading Growth Projections in Electrophysiology Segment Boston Scientific Corporation is currently subject to a class action lawsuit filed by Rosen Law…
Boston Scientific Faces Class Action Lawsuit Over Alleged Misleading Statements Boston Scientific Corporation is currently embroiled in a class action lawsuit following allegations that company manage…
Boston Scientific Faces Shareholder Scrutiny over Alleged Misleading Statements Boston Scientific Corporation is currently facing potential legal ramifications as shareholders seek justice for alleged…
Boston Scientific Faces Class Action Over Misleading Growth Projections in Electrophysiology Segment Recent developments indicate that Boston Scientific Corporation is under scrutiny due to allegation…
Boston Scientific Prepares for Key Clinical Data Presentation at ACC Session Boston Scientific Corporation is poised to host a significant investor event and live webcast on March 28, 2026, timed with…
Boston Scientific to Showcase Key Clinical Innovations at Upcoming Investor Event Boston Scientific Corporation announces an investor event scheduled for March 28, 2026, coinciding with the presentati…
Significant Recall of AXIOS Stents Amid Safety Concerns Boston Scientific Corp has initiated a recall process for certain AXIOS Stents and Electrocautery-Enhanced Delivery Systems, addressing serious…
Boston Scientific Initiates Recall of AXIOS Stents Due to Safety Concerns Boston Scientific Corp is taking decisive action by initiating the removal process for its AXIOS Stents and Electrocautery-Enh…
Boston Scientific Welcomes New Leadership to Enhance Patient Care Strategy Boston Scientific Corporation, a prominent player in the medical technology sector, fortifies its Board of Directors with the…
Strategic Leadership Changes at Boston Scientific: Enhancing Innovation and Growth Boston Scientific Corporation recently announces the election of Cathy Smith and Christophe Weber to its Board of Dir…
Executive Q&A to Map Near‑Term Priorities at TD Cowen Boston Scientific is presenting senior leadership at TD Cowen’s 46th Annual Health Care Conference to outline near‑term strategic priorities and r…
Boston Scientific Schedules Executive Q&A at TD Cowen Conference Boston Scientific is set to present at TD Cowen’s 46th Annual Health Care Conference on March 3, 2026, where Chairman and Chief Executi…
Boston Scientific credits innovation for exceptional 2025 revenue growth Innovation Drives Cardiovascular-Led Revenue Surge Boston Scientific posts fourth-quarter net sales of $5.286 billion, marking…
Boston Scientific Posts Strong 2025 Sales and Frames Future Growth Around Innovation Boston Scientific reports robust fourth‑quarter and full‑year 2025 results, driven by broad product demand and cont…
Boston Scientific Pins 2025 Breakout on Innovation and Portfolio Discipline Innovation-Led Growth, Trimmed Portfolio Boston Scientific reports that its 2025 performance is driven by a deliberate push…
Boston Scientific Expands Cardiovascular Portfolio with Penumbra Acquisition Boston Scientific Corporation announces its acquisition of Penumbra, Inc. in a landmark deal valued at approximately $14.5…
Boston Scientific Expands Cardiovascular Portfolio with Penumbra Acquisition Boston Scientific Corporation announces a strategic acquisition of Penumbra, Inc. for $14.5 billion, valuing the deal at $3…
Boston Scientific Expands Urology Portfolio with Acquisition of Valencia Technologies Boston Scientific Corporation, a prominent player in the medical technology industry, announces its definitive agr…
Boston Scientific Strengthens Urology Portfolio with Valencia Technologies Acquisition Boston Scientific Corporation takes a significant step towards enhancing its urology offerings by entering into a…
Boston Scientific Focuses on Advancing Medical Technologies Amid Market Fluctuations Boston Scientific Inc. is at the forefront of developing innovative medical technologies that aim to improve patien…
Boston Scientific: Pioneering the Future of Medical Technology through AI Integration Boston Scientific stands at the forefront of a transformative era in medical technology, where artificial intellig…
Transforming Healthcare: The Rise of AI in Medical Technology The integration of artificial intelligence (AI) in the medical technology sector marks a pivotal evolution in how healthcare is delivered.…
Revolutionizing Healthcare: AI's Role in Advancing Medical Technology The integration of artificial intelligence (AI) into the medical technology sector marks a pivotal shift in how healthcare is deli…
Boston Scientific Enhances Medical Device Offerings Amid Market Challenges Boston Scientific Inc. continues to strengthen its position in the medical device sector, focusing on innovation and expandin…
Boston Scientific Advances in Medical Technology Amid Market Fluctuations Boston Scientific Inc. is currently focusing on its innovative advancements in medical technology, which remain pivotal to the…
Boston Scientific Advances in Medical Technology Amid Market Fluctuations Boston Scientific Inc. stands at the forefront of medical technology innovation, focusing on enhancing patient care through it…
Boston Scientific: Leading the Charge in Medical Innovation Boston Scientific continues to cement its reputation as a frontrunner in the healthcare sector, leveraging its innovative medical technologi…
Boston Scientific: A Leader in Innovative Medical Technologies Boston Scientific stands out in the healthcare industry for its unwavering commitment to innovation in medical technologies. The company…
Boston Scientific: A Leader in Innovative Medical Technologies Boston Scientific solidifies its position as a key player in the healthcare industry through its commitment to innovation and strategic i…
Boston Scientific's Strategic Innovations in Medical Technology Boston Scientific Inc. continues to solidify its position as a leader in the medical technology industry through ongoing innovation and…
Boston Scientific: Pioneering Innovations in Medical Technology Boston Scientific Inc. is making significant strides in the medical technology sector, focusing on developing innovative solutions that…
Boston Scientific Prepares for Key Healthcare Conferences in Late 2025 Boston Scientific Corporation is set to participate in two major healthcare conferences in November and December 2025, showcasing…
Boston Scientific Prepares for Key Healthcare Conferences, Showcasing Innovation and Expertise Boston Scientific Corporation is set to participate in two pivotal investor conferences in the coming mon…
Boston Scientific Positions for Continued Growth Through Innovation and Strategic Expansion Boston Scientific Corporation showcases a remarkable performance in its third-quarter results, reporting rev…
Boston Scientific Achieves Strong Q3 Performance Driven by Cardiovascular Growth Boston Scientific Corporation reports robust financial results for the third quarter of 2025, marking a pivotal moment…
Boston Scientific Sees Strong Growth Ahead of Earnings Announcement Boston Scientific Corporation prepares for its upcoming quarterly earnings report, scheduled for October 22, 2025. The company has g…
Boston Scientific: Navigating Growth Amidst Market Complexity Boston Scientific demonstrates a nuanced trajectory in the medical device industry, as highlighted by recent evaluations from 21 analysts…